SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2,031.61 |
Enterprise Value ($M) | 2,045.43 |
Book Value ($M) | 247.95 |
Book Value / Share | 0.42 |
Price / Book | 8.19 |
NCAV ($M) | 195.22 |
NCAV / Share | 0.33 |
Price / NCAV | 10.41 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.55 |
Return on Assets (ROA) | -0.43 |
Return on Equity (ROE) | -0.56 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.16 |
Current Ratio | 3.16 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 341.35 |
Assets | 394.08 |
Liabilities | 146.13 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.24 |
Operating Income | -193.94 |
Net Income | -184.13 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -167.74 |
Cash from Investing | -180.32 |
Cash from Financing | 362.02 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Deep Track Capital, LP | 5.45 | 23.15 | |
13G/A | Ra Capital Management, L.p. | 9.99 | 13.88 | |
13G | Vanguard Group Inc | 5.26 | 85.16 | |
13G/A | BlackRock Inc. | 7.80 | 54.70 | |
13G/A | State Street Corp | 4.72 | 30.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,375,703 | 1,948,718 | 70.60 | |
1,634,785 | 3,017,457 | 54.18 | |
4,536,889 | 4,611,082 | 98.39 | |
3,464,036 | 2,978,251 | 116.31 | |
(click for more detail) |
Similar Companies | |
---|---|
FNCH – Finch Therapeutics Group, Inc. | FUSN – Fusion Pharmaceuticals Inc. |
GBIO – Generation Bio Co. | GILD – Gilead Sciences, Inc. |
GLUE – Monte Rosa Therapeutics, Inc. |